These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35634618)

  • 1. Observation on the efficacy of different methylprednisolone regimens in the treatment of myasthenia gravis.
    Lin X; Qi G
    Pak J Med Sci; 2022; 38(4Part-II):910-915. PubMed ID: 35634618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Fangfeng Tongsheng Granule Combined with Levocetirizine in the Treatment of Chronic Urticaria and Its Effect on Serum Complement, IL-4, IgE, and IFN-
    Xu D; Li Z; Wang Y
    Evid Based Complement Alternat Med; 2022; 2022():4012416. PubMed ID: 36212973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action.
    Zhang L; Liu J; Wang H; Zhao C; Lu J; Xue J; Gu Y; Hao C; Lin S; Lv C
    J Clin Neurosci; 2014 Sep; 21(9):1570-4. PubMed ID: 24814857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucocorticoid combined with gamma globulin in treatment of children with myasthenia gravis and its effects on immune globulin and complement of children.
    Wang MG; Huang XX; Yao D; An Q; Deng XQ
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2404-8. PubMed ID: 27338067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
    Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
    Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosuppressant fingolimod ameliorates experimental autoimmune myasthenia gravis by regulating T-cell balance and cytokine secretion.
    Luo YT; Liang YF; He H; Zhang MT; Wang R; Li HL
    Am J Transl Res; 2020; 12(6):2600-2613. PubMed ID: 32655793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of tacrolimus for treating myasthenia gravis and its influence on lymphocyte subsets.
    Bao J; Gao S; Weng Y; Zhu J; Ye H; Zhang X
    Rev Neurol (Paris); 2019; 175(1-2):65-72. PubMed ID: 30293884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acupuncture combined with western medication for ocular myasthenia gravis: a randomized controlled trial].
    Xu XP; Jiang YB; Guan LH; Ji QJ; Jin Y
    Zhongguo Zhen Jiu; 2022 Jul; 42(7):755-9. PubMed ID: 35793884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Randomized controlled clinical trial of middle-dose cyclophosphamide plus methylprednisolone for myasthenia gravis patients in crisis].
    Feng HY; Liu WB; Qiu L; Huang X; Luo CM; Li Y; Wang HY
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2473-6. PubMed ID: 23158712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nasal immune tolerance to passively transferred myasthenia gravis in young mice].
    Xu XJ; Huang Z
    Zhonghua Er Ke Za Zhi; 2008 May; 46(5):366-9. PubMed ID: 19099754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of γ-globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life.
    Wang P; Zhang S; Lv H; Qiao G; Zhong X; Li H; Zhang L
    Exp Ther Med; 2020 Nov; 20(5):104. PubMed ID: 32989383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined traditional Chinese medicine with immunosuppressive agents for patients with myasthenia gravis.
    Qi G; Gu S; Liu P; Yang H; Dong H
    Int J Clin Exp Med; 2015; 8(10):19044-50. PubMed ID: 26770531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
    Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of correlations between numbers of CD4+ CD25+ Treg cells, levels of sera anti-AChR antibodies and transfer growth factor-beta in patients with myasthenia gravis].
    Wang HB; Zhang JB; Chui LY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1036-40. PubMed ID: 18754436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of interleukin (IL)-21 and CD4
    Alahgholi-Hajibehzad M; Durmuş H; Aysal F; Gülşen-Parman Y; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Clin Exp Immunol; 2017 Nov; 190(2):201-207. PubMed ID: 28671717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center.
    Ouyang S; Yin W; Zeng Q; Li B; Zhang J; Duan W; Li Y; Liang Y; Wang J; Tan H; Yang H
    Front Immunol; 2022; 13():757841. PubMed ID: 35514988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
    Aricha R; Feferman T; Fuchs S; Souroujon MC
    J Immunol; 2008 Feb; 180(4):2132-9. PubMed ID: 18250419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
    Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
    J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.